Weight, Weight Gain, and Survival After Breast Cancer Diagnosis
Top Cited Papers
- 1 March 2005
- journal article
- breast cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (7), 1370-1378
- https://doi.org/10.1200/jco.2005.01.079
Abstract
Purpose: To determine whether weight prior to diagnosis and weight gain after diagnosis are predictive of breast cancer survival. Methods: Patients included 5,204 Nurses' Health Study participants diagnosed with incident, invasive, nonmetastatic breast cancer between 1976 and 2000; 860 total deaths, 533 breast cancer deaths, and 681 recurrences (defined as secondary lung, brain, bone, or liver cancer, and death from breast cancer) accrued to 2002. We computed the change in body mass index (BMI) from before to the first BMI reported ≥ 12 months after the date of diagnosis. Cox proportional hazards models were used to evaluate associations of categories of BMI before diagnosis and of BMI change with time to event. We stratified by smoking, menopausal status, and breast cancer–related variables. Results: In multivariate-adjusted analyses, weight before diagnosis was positively associated with breast cancer recurrence and death, but this was apparent only in never smokers. Similarly, among never-smoking women, those who gained between 0.5 and 2.0 kg/m2 (median gain, 6.0 lb; relative risk [RR], 1.35; 95% CI, 0.93 to 1.95) or more than 2.0 kg/m2 (median gain, 17.0 lb; RR, 1.64; 95% CI, 1.07 to 2.51) after diagnosis had an elevated risk of breast cancer death during follow-up (median, 9 years), compared with women who maintained their weight (test for linear trend, P = .03). Associations with weight were stronger in premenopausal than in postmenopausal women. Similar findings were noted for breast cancer recurrence and all-cause mortality. Conclusion: Weight and weight gain were related to higher rates of breast cancer recurrence and mortality, but associations were most apparent in never-smoking women.This publication has 51 references indexed in Scilit:
- Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Weight Loss in Breast Cancer Patient ManagementJournal of Clinical Oncology, 2002
- Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinomaCancer, 2001
- Hormonal and other factors in relation to survival among breast cancer patientsInternational Journal of Cancer, 2000
- Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States.Cancer Causes & Control, 1998
- The effect of body mass index and oestrogen receptor level on survival of breast cancer patients.International Journal of Epidemiology, 1997
- Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa women's health studyCancer, 1995
- An examination of obesity and breast cancer survival in post-menopausal womenBritish Journal of Cancer, 1994
- Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast CancerAnnals of Internal Medicine, 1994
- The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breastBritish Journal of Cancer, 1988